Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine

Free fatty acid receptor-1 (FFAR1) is one of the possible therapeutic targets in the search for new hepatoprotective drugs. FFAR1 agonists were found to have hypolipidemic, antifibrotic, anti-inflammatory, antiproliferative and antioxidant effects in addition to hypoglycemic action. In this work, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Pon`kina, Darya, Kuranov, Sergey, Khvostov, Mikhail, Zhukova, Nataliya, Meshkova, Yulia, Marenina, Mariya, Luzina, Olga, Tolstikova, Tatyana, Salakhutdinov, Nariman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823450/
https://www.ncbi.nlm.nih.gov/pubmed/36615590
http://dx.doi.org/10.3390/molecules28010396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823450/
https://www.ncbi.nlm.nih.gov/pubmed/36615590
http://dx.doi.org/10.3390/molecules28010396

Ejemplares similares